E. Ceresola

发表

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.

J. Mullins, A. Lazzarin, M. Clementi, 2015, The Journal of antimicrobial chemotherapy.

Epidemiological, molecular and clinical features of Enterovirus 109 infection in children and in adult stem cell transplant recipients

M. Clementi, F. Canducci, A. Piazza, 2012, Virology Journal.

Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family.

C. Tintori, C. Zamperini, E. Dreassi, 2016, Journal of medicinal chemistry.

In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir.

A. Lazzarin, M. Clementi, R. Burioni, 2013, The Journal of antimicrobial chemotherapy.

Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication

M. Scognamiglio, A. Fiorentino, E. Tramontano, 2018, PloS one.

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.

A. d’Arminio Monforte, P. Narciso, M. Capobianchi, 2012, The Journal of antimicrobial chemotherapy.

The Microbiome of the Prostate Tumor Microenvironment.

F. Montorsi, A. Salonia, A. Briganti, 2017, European Urology.

Infection and Coinfection of Human Rhinovirus C in Stem Cell Transplant Recipients

M. Clementi, F. Canducci, A. Piazza, 2013, Clinical & developmental immunology.

Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation.

R. Ferrarese, F. Canducci, A. Preti, 2018, European review for medical and pharmacological sciences.

The role of infections and coinfections with newly identified and emerging respiratory viruses in children

M. Clementi, F. Canducci, E. Ceresola, 2012, Virology Journal.

Natural Product Kuwanon‐L Inhibits HIV‐1 Replication through Multiple Target Binding

C. Tintori, M. Botta, R. Ferrarese, 2017, Chembiochem : a European journal of chemical biology.

Inhibition of HIV‐1 Reverse Transcriptase Dimerization by Small Molecules

C. Tintori, M. Botta, M. Clementi, 2016, Chembiochem : a European journal of chemical biology.

The role of infections and coinfections with newly identified and emerging respiratory viruses in children

M. Clementi, F. Canducci, E. Ceresola, 2012, Virology Journal.

Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation

C. Foglieni, M. Clementi, R. Burioni, 2016, Scientific Reports.

Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era.

R. Ferrarese, F. Canducci, A. Preti, 2018, European review for medical and pharmacological sciences.

Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides

C. Tintori, C. Zamperini, E. Dreassi, 2018, PloS one.

The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir.

F. Nicoletti, M. Clementi, Y. Al-Abed, 2011, Antiviral research.

Kuwanon‐L as a New Allosteric HIV‐1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation

C. Tintori, M. Botta, Z. Debyser, 2015, Chembiochem : a European journal of chemical biology.

2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors

C. Tintori, C. Zamperini, M. Botta, 2014, Antimicrobial Agents and Chemotherapy.

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

A. Lazzarin, M. Clementi, L. Galli, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.

Adriano Lazzarin, Massimo Clementi, A. Lazzarin, 2011, The Journal of infectious diseases.

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.

A. Lazzarin, M. Clementi, F. Canducci, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Microbiome of the Prostate Tumor Microenvironment.

F. Montorsi, A. Salonia, A. Briganti, 2017, European urology.

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.

F. Canducci, A. Castagna, S. Nozza, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Natural Product Kuwanon‐L Inhibits HIV‐1 Replication through Multiple Target Binding

C. Tintori, M. Botta, R. Ferrarese, 2017, Chembiochem : a European journal of chemical biology.